Cite
MLA Citation
David Planchard et al.. “Dabrafenib plus trametinib in patients with previously treated BRAFV600E-mutant metastatic non-small cell lung cancer: an open-label, multicentre phase 2 trial.” Lancet oncology, vol. 17, no. 7, n.d., pp. 984–993. http://access.bl.uk/ark:/81055/vdc_100033361369.0x00003d